INTI
PINK Inhibitor Therapeutics Inc.$0.1099 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.1099, and at the day’s high of $0.1099
- YTD change
- +42.73%
- vs 20-day SMA
- +30.71%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+0.03 (+32.73%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 11.2% away from all-time highs of $0.1238
- INTI is up 43% since the beginning of the year
- INTI is up 43% over the past 12 months
- INTI is up 35% over the past 1 month
INTI reads very good: the 12-month move is +141.5%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0489
- Last 5 days
- +9.90%
- vs 8-day SMA
- +29.00%
No alerts for INTI in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Inhibitor Therapeutics, Inc. engages in the discovery, development, and commercialization of therapeutics for patients with cancer. It focuses on oral formulation of Itraconazole, for treatment of prostate and lung cancers. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.